MEK1 inhibitor selumetinib sensitizes B-cell acute lymphoblastic leukemia (B-ALL) cells to dexamethasone by modulating autophagy
Authors: Polak A, Kiliszek P, Sewastianik T., Szydlowski M., Jablonska E., Prusisz W., Bialopiotrowicz E., Markowicz S., Nowak E., Grygorowicz M., Nowis D., Bojarczuk K., Golab J., Juszczynski P
Published in: 19th Congress of the European Hematology Association, 12-15 June, 2014, Milan, Italy
Publication type: conference